Ginkgo Bioworks Holdings, Inc.

DNA XNYS BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Market Cap

610M

Short interest (May 15)

6.9%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.26%

↓ 8.6%

Available Shares

900K

↓ 10.9%

Price Chart

Company Overview

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Company Info

Exchange: NYSE
Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
CIK: 0001830214
Asset Type: CS

Market Data

Market Cap: $609,477,501
Employees: 485
Status: Active

Short Interest

Current Borrow Fee 0.26%
Range: 0.26% - 0.27%
Available Shares 900K
Range: 650K - 850K

Recent Changes

Fee Change: ↓ 3.7%
Available Change: ↑ 13.3%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime